查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1848389

生物技术原料市场预测至2032年：按产品类型、来源、生产方法、应用、最终用户和地区分類的全球分析

Biotech Ingredients Market Forecasts to 2032 - Global Analysis By Type, Source, Production Method, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，预计 2025 年全球生技原料市场规模将达到 26.1 亿美元，到 2032 年将达到 50.3 亿美元，预测期内复合年增长率为 9.8%。

生物技术成分是指利用先进生物技术（例如发酵、酵素催化和基因改造）生产的成分。它们广泛应用于食品、医药、化妆品和农业领域，以提升产品性能、营养价值和安全性。透过利用细胞、微生物和酶，这些成分能够开发出功能性强、生物活性高且环境永续的产品，为传统的化学生产方法提供了高效且创新的替代方案。

对机能性食品和营养补充剂的需求日益增长

全球健康意识的增强推动了机能性食品和膳食补充剂中生物技术衍生成分的需求。这些成分提供针对性的健康益处，包括增强免疫力、消化器官系统健康和平衡新陈代谢，因此被纳入日常饮食中。生物技术的创新使得胜肽、酵素和益生菌等成分的精准配比成为可能，从而提高了功效。个人化营养趋势和预防性医疗保健模式正在加速食品饮料产业的普及。监管机构对健康声明和洁净标示配方的支持也增强了市场信心。随着消费者寻求天然、科学的解决方案，生物技术成分正成为下一代健康产品的核心。

高昂的生产和研发成本

优化产量、生物利用度和安全性需要先进的研发投入，通常需要数年时间。从实验室到商业化生产的规模化生产面临技术难题和成本效率低下的问题。监管合规，包括临床检验和安全性核准，进一步加重了企业的财务负担。智慧财产权保护和专利申请也增加了主导企业的营运成本。这些挑战阻碍了中小企业的发展，并延缓了新型成分的上市时间。因此，许多公司正在采取分阶段开发策略或寻求合作伙伴关係来降低财务风险。

酵素和微生物技术的创新

客製化酵素正在提升原料生产的反应特异性、稳定性和可扩展性。包括基因工程菌株在内的微生物平台正被优化，用于高产率生物合成维生素、胺基酸和生物活性胜肽。这些技术减少了对化学合成的依赖，并支持永续的生产方式。人工智慧和生物资讯学的融合正在加速菌株筛选和製程优化。Start-Ups和研究机构正在合作，将新型微生物途径商业化，应用于特定领域。这波创新浪潮有望重塑原料组合，并扩大食品、製药和化妆品产业的市场进入。

来自合成替代品的激烈竞争

现有化学品製造商利用规模经济和精简的供应链来降低生技产品的价格。在某些情况下，合成替代品的功能与生物技术产品相当，这使得价格较高的生物技术产品难以获得市场认可。关于天然与合成标籤的监管不确定性进一步加剧了消费者认知的混乱。市场宣传和品牌定位在影响消费者偏好发挥关键作用。如果生物技术成分在功效或永续性方面没有明显的差异，就有可能被市场拒之门外。持续创新和透明沟通对于抵御合成替代品的衝击，捍卫市场份额至关重要。

新冠疫情的影响：

新冠疫情再形成了生物技术原料的研发重点，将重点转向免疫力、卫生和韧性。支持呼吸系统健康、缓解压力和具有抗病毒特性的原料需求激增。供应链中断影响了原材料可得性，并延误了生产计划。各公司加速数位转型，采用远距研发工具和云端基础的协作平台。然而，预算重新分配和营运限制阻碍了非必需创新专案的进展。后疫情时代的策略重点转向敏捷性、健康防范和多元化采购，以应对未来的挑战。

预计在预测期内，单株抗体细分市场将是最大的细分市场。

由于单株抗体在治疗和诊断药物中的广泛应用，预计在预测期内，单株抗体领域将占据最大的市场份额。这些生物製药具有高度特异性和疗效，能够针对疾病通路，使其成为现代医学不可或缺的一部分。生物技术的进步提高了抗体的稳定性、扩充性和递送机制。自体免疫疾病、癌症和感染疾病的日益普遍正在推动对抗体疗法的需求。製药公司正大力投资单株抗体研发管线和生物相似药的开发。监管核准和报销机制也为市场扩张提供了支持。

预计在预测期内，化妆品製造商板块将实现最高的复合年增长率。

在预测期内，受清洁、功能性和生物活性配方需求的推动，化妆品製造商预计将实现最高成长率。消费者越来越倾向于选择具有科学检验功效的护肤和个人保健产品。胜肽、酵素和发酵萃取物等生物技术成分具有抗衰老、保湿和增强皮肤屏障的功效。递送系统和包封技术的创新正在提升成分的性能和稳定性。各大品牌正利用生物技术在竞争激烈的市场中脱颖而出，并符合安全性和功效的监管标准。社群媒体和网红行销正在提升消费者对生技化妆品的认知度。

占比最大的地区：

在预测期内，亚太地区预计将占据最大的市场份额，这主要得益于其强大的製造业生态系统和日益增强的健康意识。中国、印度、日本和韩国等国家正在增加对生物技术基础设施和研发能力的投入。传统医学的融合以及膳食补充剂的消费正在推动对天然和功能性成分的需求。政府支持生物技术创新和出口竞争力的措施正在促进市场成长。都市化和可支配收入的增加正在扩大消费者获得优质健康产品的管道。区域内企业正在建立策略联盟，以扩大生产和分销。

复合年增长率最高的地区：

预计在预测期内，北美将呈现最高的复合年增长率，这主要得益于前沿研究和健全的法规结构。美国和加拿大拥有众多领先的生物技术公司和学术机构，它们正推动原料创新。消费者对透明度、永续性和功效的需求正在影响产品开发策略。创业投资和联邦政府的资助正在支持专注于新型生物合成途径的新兴企业。该地区对个人化营养和预防性医疗保健的重视正在推动生物技术原料的应用。製药、食品和化妆品产业之间的策略合作正在促进跨产业创新。

免费客製化服务：

订阅本报告的用户可享有以下免费客製化服务之一：

  • 公司简介
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 原始研究资料
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生技原料市场（按类型划分）

  • 活性药物成分（API）
  • 生物相似药
  • 核酸
  • 酵素
  • 胜肽
  • 单株抗体
  • 多醣
  • 其他类型

6. 全球生物技术原料市场（供应商）

  • 微生物
  • 动物
  • 植物
  • 藻类
  • 其他资讯来源

7. 全球生技原料市场依生产方法划分

  • 发酵
  • 从自然资源中提取资源
  • 重组DNA技术
  • 合成生物学
  • 细胞培养技术

8. 全球生技原料市场（依应用领域划分）

  • 製药
  • 农业和动物饲料
  • 个人护理及化妆品
  • 工业生物技术
  • 食品/饮料
  • 营养补充品
  • 其他用途

9. 全球生物技术原料市场（依最终用户划分）

  • 製药和生物製药公司
  • 契约製造组织（CMO）
  • 化妆品製造商
  • 研究机构
  • 食品加工公司
  • 其他最终用户

第十章：全球生技原物料市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十二章 企业概况

  • Novozymes A/S
  • DuPont
  • dsm-firmenich
  • Novus International, Inc.
  • AB Enzymes GmbH
  • Evonik Industries AG
  • BASF SE
  • Amyris, Inc.
  • Givaudan
  • Ginkgo Bioworks
  • Chr. Hansen Holding A/S
  • Codexis, Inc.
  • Kerry Group plc
  • Lonza Group
  • Corbion NV
Product Code: SMRC31638

According to Stratistics MRC, the Global Biotech Ingredients Market is accounted for $2.61 billion in 2025 and is expected to reach $5.03 billion by 2032 growing at a CAGR of 9.8% during the forecast period. Biotech ingredients are components produced using advanced biotechnological techniques such as fermentation, enzyme catalysis, or genetic modification. They are utilized across sectors including food, pharma, cosmetics, and agriculture to enhance product performance, nutritional content, and safety. These ingredients allow for the development of functional, bioactive, and environmentally sustainable products by employing cells, microbes, or enzymes, offering an efficient and innovative alternative to conventional chemical-based production methods.

Market Dynamics:

Driver:

Rising demand for functional foods and nutraceuticals

The global surge in health-conscious consumers is propelling demand for biotech-derived ingredients in functional foods and nutraceuticals. These ingredients offer targeted health benefits, such as immune support, digestive wellness, and metabolic balance, driving their inclusion in daily diets. Biotech innovations are enabling precise formulation of ingredients like peptides, enzymes, and probiotics to enhance efficacy. Personalized nutrition trends and preventive healthcare models are accelerating adoption across food and beverage sectors. Regulatory support for health claims and clean-label formulations is also boosting market confidence. As consumers seek natural, science-backed solutions, biotech ingredients are becoming central to next-gen wellness products.

Restraint:

High production and R&D costs

Advanced R&D is required to optimize yield, bioavailability, and safety, often demanding multi-year investments. Scaling up from lab to commercial production introduces technical hurdles and cost inefficiencies. Regulatory compliance, including clinical validation and safety approvals, adds further financial strain. Intellectual property protection and patent filings increase overhead for innovation-driven firms. These challenges deter smaller players and slow down time-to-market for novel ingredients. As a result, many companies adopt phased development strategies or seek partnerships to mitigate financial risks.

Opportunity:

Innovations in enzyme and microbial technology

Tailored enzymes are improving reaction specificity, stability, and scalability in ingredient production. Microbial platforms, including genetically modified strains, are being optimized for high-yield biosynthesis of vitamins, amino acids, and bioactive peptides. These technologies reduce reliance on chemical synthesis and support sustainable manufacturing practices. Integration with AI and bioinformatics is accelerating strain selection and process optimization. Startups and research institutions are collaborating to commercialize novel microbial pathways for niche applications. This wave of innovation is expected to reshape ingredient portfolios and expand market access across food, pharma, and cosmetic sectors.

Threat:

Intense competition from synthetic alternatives

Established chemical manufacturers leverage economies of scale and streamlined supply chains to undercut biotech pricing. In some cases, synthetic versions offer comparable functionality, making it difficult to justify premium biotech options. Regulatory ambiguity around natural vs. synthetic labeling further blurs consumer perception. Marketing claims and brand positioning play a critical role in influencing buyer preferences. Without clear differentiation in efficacy or sustainability, biotech ingredients risk being sidelined. Continuous innovation and transparent communication are essential to defend market share against synthetic substitutes.

Covid-19 Impact:

The COVID-19 pandemic reshaped priorities in biotech ingredient development, emphasizing immunity, hygiene, and resilience. Demand surged for ingredients supporting respiratory health, stress reduction, and antiviral properties. Supply chain disruptions affected raw material availability and delayed production timelines. Companies accelerated digital transformation, adopting remote R&D tools and cloud-based collaboration platforms. However, budget reallocations and operational constraints slowed non-essential innovation pipelines. Post-pandemic strategies now focus on agility, health preparedness, and diversified sourcing to withstand future disruptions.

The monoclonal antibodies segment is expected to be the largest during the forecast period

The monoclonal antibodies segment is expected to account for the largest market share during the forecast period, due to its widespread application in therapeutic and diagnostic products. These biologics offer high specificity and efficacy in targeting disease pathways, making them indispensable in modern medicine. Biotech advancements have improved antibody stability, scalability, and delivery mechanisms. Growing prevalence of autoimmune disorders, cancers, and infectious diseases is driving demand for antibody-based treatments. Pharmaceutical companies are investing heavily in monoclonal antibody pipelines and biosimilar development. Regulatory approvals and reimbursement frameworks are supporting market expansion.

The cosmetic manufacturers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetic manufacturers segment is predicted to witness the highest growth rate, driven by demand for clean, functional, and bioactive formulations. Consumers are increasingly seeking skincare and personal care products with scientifically validated benefits. Biotech ingredients such as peptides, enzymes, and fermented extracts offer anti-aging, hydration, and skin barrier support. Innovations in delivery systems and encapsulation are enhancing ingredient performance and shelf stability. Brands are leveraging biotech to differentiate in a crowded market and meet regulatory standards for safety and efficacy. Social media and influencer marketing are amplifying awareness of biotech-based cosmetics.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fueled by robust manufacturing ecosystems and rising health awareness. Countries like China, India, Japan, and South Korea are investing in biotech infrastructure and R&D capabilities. Traditional medicine integration and dietary supplement consumption are driving demand for natural and functional ingredients. Government initiatives supporting biotech innovation and export competitiveness are accelerating market growth. Urbanization and rising disposable incomes are expanding consumer access to premium wellness products. Regional players are forming strategic alliances to scale production and distribution.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, propelled by cutting-edge research and strong regulatory frameworks. The U.S. and Canada are home to leading biotech firms and academic institutions driving ingredient innovation. Consumer demand for transparency, sustainability, and efficacy is shaping product development strategies. Venture capital and federal funding are supporting startups focused on novel biosynthesis pathways. The region's emphasis on personalized nutrition and preventive healthcare is boosting biotech ingredient adoption. Strategic collaborations between pharma, food, and cosmetic sectors are fostering cross-industry innovation.

Key players in the market

Some of the key players in Biotech Ingredients Market include Novozymes A/S, DuPont, dsm-firmenich, Novus International, Inc., AB Enzymes GmbH, Evonik Industries AG, BASF SE, Amyris, Inc., Givaudan, Ginkgo Bioworks, Chr. Hansen Holding A/S, Codexis, Inc., Kerry Group plc, Lonza Group, and Corbion N.V.

Key Developments:

In September 2025, DuPont has signed an agreement to acquire Sinochem RO Memtech Co., Ltd. to expand its reverse osmosis (RO) manufacturing footprint into China and the Asia Pacific region. With advanced membrane and fabrication production technologies, the acquisition increases DuPont's capacity to meet the growing demand in the region for FilmTec(TM) elements for industrial water purification and reuse.

In September 2025, dsm-firmenich launches four new Dairy Safe(TM) culture rotations. These all-in-one, label-friendly solutions deliver assured bioprotection through improved phage robustness as well as greater temperature resistance, controlled eye formation, consistent acidification, and enhanced flavor development for premium semi-hard, hard, and continental-style cheese varieties.

Types Covered:

  • Active Pharmaceutical Ingredients (APIs)
  • Biosimilars
  • Nucleic Acids
  • Enzymes
  • Peptides
  • Monoclonal Antibodies
  • Polysaccharides
  • Other Types

Sources Covered:

  • Microbial
  • Animal
  • Plant
  • Algae
  • Other Sources

Production Methods Covered:

  • Fermentation
  • Extraction from Natural Sources
  • Recombinant DNA Technology
  • Synthetic Biology
  • Cell Culture Technology

Applications Covered:

  • Pharmaceuticals
  • Agriculture & Animal Feed
  • Personal Care & Cosmetics
  • Industrial Biotechnology
  • Food & Beverages
  • Nutraceuticals
  • Other Applications

End Users Covered:

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Cosmetic Manufacturers
  • Research Institutes
  • Food Processing Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biotech Ingredients Market, By Type

  • 5.1 Introduction
  • 5.2 Active Pharmaceutical Ingredients (APIs)
  • 5.3 Biosimilars
  • 5.4 Nucleic Acids
  • 5.5 Enzymes
  • 5.6 Peptides
  • 5.7 Monoclonal Antibodies
  • 5.8 Polysaccharides
  • 5.9 Other Types

6 Global Biotech Ingredients Market, By Source

  • 6.1 Introduction
  • 6.2 Microbial
  • 6.3 Animal
  • 6.4 Plant
  • 6.5 Algae
  • 6.6 Other Sources

7 Global Biotech Ingredients Market, By Production Method

  • 7.1 Introduction
  • 7.2 Fermentation
  • 7.3 Extraction from Natural Sources
  • 7.4 Recombinant DNA Technology
  • 7.5 Synthetic Biology
  • 7.6 Cell Culture Technology

8 Global Biotech Ingredients Market, By Application

  • 8.1 Introduction
  • 8.2 Pharmaceuticals
  • 8.3 Agriculture & Animal Feed
  • 8.4 Personal Care & Cosmetics
  • 8.5 Industrial Biotechnology
  • 8.6 Food & Beverages
  • 8.7 Nutraceuticals
  • 8.8 Other Applications

9 Global Biotech Ingredients Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical & Biopharmaceutical Companies
  • 9.3 Contract Manufacturing Organizations (CMOs)
  • 9.4 Cosmetic Manufacturers
  • 9.5 Research Institutes
  • 9.6 Food Processing Companies
  • 9.7 Other End Users

10 Global Biotech Ingredients Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Novozymes A/S
  • 12.2 DuPont
  • 12.3 dsm-firmenich
  • 12.4 Novus International, Inc.
  • 12.5 AB Enzymes GmbH
  • 12.6 Evonik Industries AG
  • 12.7 BASF SE
  • 12.8 Amyris, Inc.
  • 12.9 Givaudan
  • 12.10 Ginkgo Bioworks
  • 12.11 Chr. Hansen Holding A/S
  • 12.12 Codexis, Inc.
  • 12.13 Kerry Group plc
  • 12.14 Lonza Group
  • 12.15 Corbion N.V.

List of Tables

  • Table 1 Global Biotech Ingredients Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Biotech Ingredients Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Biotech Ingredients Market Outlook, By Active Pharmaceutical Ingredients (APIs) (2024-2032) ($MN)
  • Table 4 Global Biotech Ingredients Market Outlook, By Biosimilars (2024-2032) ($MN)
  • Table 5 Global Biotech Ingredients Market Outlook, By Nucleic Acids (2024-2032) ($MN)
  • Table 6 Global Biotech Ingredients Market Outlook, By Enzymes (2024-2032) ($MN)
  • Table 7 Global Biotech Ingredients Market Outlook, By Peptides (2024-2032) ($MN)
  • Table 8 Global Biotech Ingredients Market Outlook, By Monoclonal Antibodies (2024-2032) ($MN)
  • Table 9 Global Biotech Ingredients Market Outlook, By Polysaccharides (2024-2032) ($MN)
  • Table 10 Global Biotech Ingredients Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 11 Global Biotech Ingredients Market Outlook, By Source (2024-2032) ($MN)
  • Table 12 Global Biotech Ingredients Market Outlook, By Microbial (2024-2032) ($MN)
  • Table 13 Global Biotech Ingredients Market Outlook, By Animal (2024-2032) ($MN)
  • Table 14 Global Biotech Ingredients Market Outlook, By Plant (2024-2032) ($MN)
  • Table 15 Global Biotech Ingredients Market Outlook, By Algae (2024-2032) ($MN)
  • Table 16 Global Biotech Ingredients Market Outlook, By Other Sources (2024-2032) ($MN)
  • Table 17 Global Biotech Ingredients Market Outlook, By Production Method (2024-2032) ($MN)
  • Table 18 Global Biotech Ingredients Market Outlook, By Fermentation (2024-2032) ($MN)
  • Table 19 Global Biotech Ingredients Market Outlook, By Extraction from Natural Sources (2024-2032) ($MN)
  • Table 20 Global Biotech Ingredients Market Outlook, By Recombinant DNA Technology (2024-2032) ($MN)
  • Table 21 Global Biotech Ingredients Market Outlook, By Synthetic Biology (2024-2032) ($MN)
  • Table 22 Global Biotech Ingredients Market Outlook, By Cell Culture Technology (2024-2032) ($MN)
  • Table 23 Global Biotech Ingredients Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global Biotech Ingredients Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 25 Global Biotech Ingredients Market Outlook, By Agriculture & Animal Feed (2024-2032) ($MN)
  • Table 26 Global Biotech Ingredients Market Outlook, By Personal Care & Cosmetics (2024-2032) ($MN)
  • Table 27 Global Biotech Ingredients Market Outlook, By Industrial Biotechnology (2024-2032) ($MN)
  • Table 28 Global Biotech Ingredients Market Outlook, By Food & Beverages (2024-2032) ($MN)
  • Table 29 Global Biotech Ingredients Market Outlook, By Nutraceuticals (2024-2032) ($MN)
  • Table 30 Global Biotech Ingredients Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 31 Global Biotech Ingredients Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Biotech Ingredients Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2024-2032) ($MN)
  • Table 33 Global Biotech Ingredients Market Outlook, By Contract Manufacturing Organizations (CMOs) (2024-2032) ($MN)
  • Table 34 Global Biotech Ingredients Market Outlook, By Cosmetic Manufacturers (2024-2032) ($MN)
  • Table 35 Global Biotech Ingredients Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 36 Global Biotech Ingredients Market Outlook, By Food Processing Companies (2024-2032) ($MN)
  • Table 37 Global Biotech Ingredients Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.